Home Supplements How We Rate Blog
Thearubigins (heterogeneous black tea polyphenols)

Thearubigins

Research reviewed: Up until 03/2026

Thearubigins (Thearubigins (heterogeneous black tea polyphenols)) is a dietary supplement with 8 published peer-reviewed studies involving 5,942 participants, researched for Cardiovascular Health & Cholesterol, Antioxidant Properties, Gut Health & Microbiome Effects and 1 more areas.

8
Studies
5,942
Participants
2002–2022
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Cardiovascular Health & Cholesterol

Moderate
2 studies 1 of 2 positive 4,857 participants

Antioxidant Properties

Moderate
2 studies 1 of 2 positive 40 participants 1 human

Gut Health & Microbiome Effects

Moderate
2 studies 1 of 2 positive 45 participants 1 human

Anti-inflammatory & Reviews

Moderate
2 studies 1 of 2 positive 1,000 participants 1 human

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

0/8
Randomised
0/8
Double-Blind
0/8
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2003)
50
Study 2 (2009)
4,807
Study 3 (2002)
0
Study 4 (2008)
40
Study 5 (2020)
45
Study 6 (2014)
0
Study 7 (2012)
1,000
Study 8 (2022)
0

Research Timeline

When the studies were published

1
2002
1
2003
1
2008
1
2009
1
2012
1
2014
1
2020
1
2022

All Studies

Detailed breakdown of each trial. Click to expand.

Cardiovascular Health & Cholesterol

1

To evaluate black tea consumption (thearubigin-rich) on cardiovascular risk biomarkers.

2003 50 participants 4 weeks 5 cups black tea daily (600 mg thearubigins estimated)
Human Study Positive

Study Type

RCT

Purpose

To evaluate black tea consumption (thearubigin-rich) on cardiovascular risk biomarkers.

Dose

5 cups black tea daily (600 mg thearubigins estimated)

Participants

50 adults with borderline high cholesterol

Duration

4 weeks

Results

Black tea consumption produced significant reductions in LDL-C (-7%) and improvements in FMD; platelet aggregation decreased vs water control.

How They Measured It

Serum lipids, CRP, fibrinogen, platelet aggregation

Read full study
2

To investigate black tea consumption and stroke risk in a Dutch cohort.

2009 4807 participants 15 years follow-up Tea consumption (observational)
Human Study Mixed

Study Type

Prospective cohort

Purpose

To investigate black tea consumption and stroke risk in a Dutch cohort.

Dose

Tea consumption (observational)

Participants

4807 Dutch adults in Rotterdam Study

Duration

15 years follow-up

Results

Highest black tea intake associated with 29% lower stroke risk; association stronger for ischaemic stroke; thearubigins cited as likely bioactive.

How They Measured It

Tea intake FFQ; stroke incidence from national registry

Read full study

Antioxidant Properties

3

To characterise the antioxidant capacity of thearubigins relative to theaflavins and catechins.

2002 ? participants Acute 0.05-1 mg/mL thearubigins
Review/Other Mixed

Study Type

In vitro comparative study

Purpose

To characterise the antioxidant capacity of thearubigins relative to theaflavins and catechins.

Dose

0.05-1 mg/mL thearubigins

Participants

Cell-free assay

Duration

Acute

Results

Thearubigins showed high aggregate ORAC values and potent lipid peroxidation inhibition; lower per-molecule potency than theaflavins but substantially higher in mass terms due to complex polymerisation.

How They Measured It

DPPH, ORAC, iron chelation, lipid peroxidation inhibition

Read full study
4

To assess plasma antioxidant status after black tea vs black tea polyphenol extract consumption.

2008 40 participants 4-week crossover 4 cups black tea daily vs thearubigin-enriched extract
Human Study Positive

Study Type

RCT

Purpose

To assess plasma antioxidant status after black tea vs black tea polyphenol extract consumption.

Dose

4 cups black tea daily vs thearubigin-enriched extract

Participants

40 healthy adults

Duration

4-week crossover

Results

Both black tea and thearubigin extract significantly increased plasma antioxidant capacity vs water; extract showed slightly higher and more sustained peak.

How They Measured It

Plasma ORAC, FRAP, ascorbate, uric acid over 4 hours

Read full study

Gut Health & Microbiome Effects

5

To evaluate black tea polyphenol (thearubigin-rich) supplementation on gut microbiota composition.

2020 45 participants 8 weeks 700 mg black tea polyphenols daily
Human Study Positive

Study Type

RCT

Purpose

To evaluate black tea polyphenol (thearubigin-rich) supplementation on gut microbiota composition.

Dose

700 mg black tea polyphenols daily

Participants

45 healthy adults

Duration

8 weeks

Results

Black tea polyphenols significantly increased Bifidobacterium and Lactobacillus spp. while reducing Clostridium perfringens; SCFA production enhanced.

How They Measured It

16S rRNA sequencing of faecal samples; short-chain fatty acid analysis

Read full study
6

To investigate the fermentation of thearubigins by human gut microbiota and metabolite production.

2014 ? participants 24-48 hours Thearubigins at physiological concentrations
Review/Other Mixed

Study Type

In vitro colonic fermentation study

Purpose

To investigate the fermentation of thearubigins by human gut microbiota and metabolite production.

Dose

Thearubigins at physiological concentrations

Participants

Human faecal batch fermentation model

Duration

24-48 hours

Results

Thearubigins were extensively fermented; produced numerous bioactive metabolites including hydroxyphenylpropionic acids with anti-inflammatory properties.

How They Measured It

HPLC metabolite profiling; microbiota composition by 16S; SCFA quantification

Read full study

Anti-inflammatory & Reviews

7

To investigate black tea intake and markers of systemic inflammation in an elderly cohort.

2012 1000 participants Cross-sectional Tea consumption (observational)
Human Study Positive

Study Type

Observational study

Purpose

To investigate black tea intake and markers of systemic inflammation in an elderly cohort.

Dose

Tea consumption (observational)

Participants

1000+ adults aged 65+ in ESTHER cohort

Duration

Cross-sectional

Results

Regular black tea drinkers had significantly lower serum CRP and IL-6; thearubigin content linked to anti-inflammatory benefit.

How They Measured It

Serum CRP, IL-6, fibrinogen by FFQ and biobank

Read full study
8

To review the health effects of thearubigins and their role in black tea's bioactivity.

2022 ? participants Review Varied
Review/Other Mixed

Study Type

Systematic review

Purpose

To review the health effects of thearubigins and their role in black tea's bioactivity.

Dose

Varied

Participants

Multiple studies reviewed

Duration

Review

Results

Thearubigins constitute ~60-70% of black tea solids and contribute substantially to cardiovascular, antioxidant, and gut microbiome benefits; their chemical complexity makes isolation and standardisation challenging.

How They Measured It

Literature synthesis

Read full study

Frequently Asked Questions

Common questions about Thearubigins research

What does the research say about Thearubigins?

There are currently 8 peer-reviewed studies on Thearubigins (Thearubigins (heterogeneous black tea polyphenols)), involving 5,942 total participants. Research covers Cardiovascular health, Antioxidant protection, Gut health and 1 more areas. The overall evidence strength is rated as Strong.

How strong is the evidence for Thearubigins?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (5 human studies), and reported outcomes.

What health goals has Thearubigins been studied for?

Thearubigins has been researched for: Cardiovascular health, Antioxidant protection, Gut health, Anti-inflammatory. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Thearubigins based on human trials?

Yes, 5 out of 8 studies are human trials. Human trials carry more weight in our evidence scoring system.